When does APTOSE BIOSCIENCES INC (APS.CA) report earnings?
APTOSE BIOSCIENCES INC (APS.CA) will report earnings on 2026-03-26, after the market close.
TSX:APS • CA03835T4081
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APTOSE BIOSCIENCES INC (APS.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-02 | Jones Trading | Maintains | Buy |
| 2022-11-02 | HC Wainwright | Maintains | Buy |
| 2022-08-03 | Jones Trading | Maintains | Buy |
| 2022-06-03 | Jones Trading | Downgrade | Buy |
| 2022-03-24 | RBC Royalbank | Upgrade | Outperform |
| 2022-03-23 | Jones Trading | Initiate | Buy |
| 2022-03-23 | HC Wainwright | Upgrade | Buy |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 80.52% | N/A 44.11% | N/A 37.01% | ||||||||||
| EBITDA YoY % growth | -12.782M | -14.157M -10.76% | -11.742M 17.06% | -29.02M -147.15% | -26.705M 7.98% | -55.616M -108.26% | -65.297M -17.41% | -42.482M 34.94% | -52.268M -23.04% | N/A 38.92% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -12.857M | -14.273M -11.01% | -11.826M 17.14% | -29.107M -146.13% | -26.857M 7.73% | -55.768M -107.65% | -65.447M -17.36% | -42.602M 34.91% | -52.356M -22.90% | N/A 41.13% | N/A 0.74% | N/A 17.99% | N/A 167.04% | N/A 537.81% | N/A 110.72% | N/A 59.03% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -431.36 | -503.19 -16.65% | N/A 20.46% | -377.99 5.57% | -234.00 38.09% | -301.50 -28.85% | -328.50 -8.96% | -202.50 38.36% | -231.60 -14.37% | -47.24 79.60% | N/A 95.27% | N/A 20.09% | N/A 125.51% | N/A 478.31% | N/A 105.75% | N/A 52.70% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -2.54 88.40% | -2.50 80.63% | -0.81 92.74% | -0.91 32.10% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -7.14M 26.72% | -7.344M -0.31% | N/A | N/A |
| EBIT Q2Q % growth | -5.911M 39.44% | -6.217M 15.36% | -13.005M -86.72% | -14.79M -137.90% |
All data in USD
APTOSE BIOSCIENCES INC (APS.CA) will report earnings on 2026-03-26, after the market close.
The consensus EPS estimate for the next earnings of APTOSE BIOSCIENCES INC (APS.CA) is -2.54 CAD and the consensus revenue estimate is 0 CAD.
The consensus rating for APTOSE BIOSCIENCES INC (APS.CA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.